- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 5, 2025 | 22.95M sh |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $21.21M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $8.87M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $167.72M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $164.13M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $471.62M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $481.22M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $163.25M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $147.06M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $664.59M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $655.48M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 23.06M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 23.02M sh |
| Dividends Paid | Q2 2025 · Mar 31, 2024 | $27.31M |
| Capex | Q2 2025 · Mar 31, 2024 | $22.18M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $36.85M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $159.97M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $153.86M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $170.84M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.35 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.68 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.35 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.69 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $9.52M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $18.93M |
| Net Income | Q2 2025 · Mar 31, 2024 | $7.96M |
| Net Income | Q2 2025 · Mar 31, 2024 | $15.72M |
| Net Income | Q2 2025 · Dec 31, 2023 | $7.76M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $11.26M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $22.06M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $90.36M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $179.12M |
| Revenue | Q2 2025 · Mar 31, 2024 | $308.09M |
| Revenue | Q2 2025 · Mar 31, 2024 | $609.84M |